6-Methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole

ID: ALA4784346

Chembl Id: CHEMBL4784346

PubChem CID: 137193151

Max Phase: Preclinical

Molecular Formula: C13H14N2O

Molecular Weight: 214.27

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc2[nH]c3c(c12)CCN=C3C

Standard InChI:  InChI=1S/C13H14N2O/c1-8-13-9(6-7-14-8)12-10(15-13)4-3-5-11(12)16-2/h3-5,15H,6-7H2,1-2H3

Standard InChI Key:  RFGOJFHLZUEUIV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4784346

    ---

Associated Targets(Human)

HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ptgs2 Cyclooxygenase-2 (1939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 214.27Molecular Weight (Monoisotopic): 214.1106AlogP: 2.54#Rotatable Bonds: 1
Polar Surface Area: 37.38Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.09CX LogP: 1.67CX LogD: 0.90
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.78Np Likeness Score: 1.03

References

1. Uddin MJ,Xu S,Crews BC,Aleem AM,Ghebreselasie K,Banerjee S,Marnett LJ.  (2020)  Harmaline Analogs as Substrate-Selective Cyclooxygenase-2 Inhibitors.,  11  (10): [PMID:33062168] [10.1021/acsmedchemlett.9b00555]
2. Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R..  (2021)  β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.,  64  (3.0): [PMID:33528252] [10.1021/acs.jmedchem.0c01887]

Source